|
Miscellaneous
Topics
General Articles of Special Interest
to Medical Oncologists
General
Articles of Special Interest to Surgical Oncologists
Miscellaneous
Cancer
and age in the USA [Review].
Balducci L, Beghe' C. Critical Reviews in Oncology-Hematology.
37(2):137-145, 2001 Feb.
Disparities
in cancer diagnosis and survival.
Bradley CJ, Given CW, Roberts C. Cancer Cytopathology. 91(1):178-188,
2001 Jan 1.
Interval
cancer peer review in East Anglia: Implications for monitoring
doctors as well as the NHS breast screening programme.
Britton PD, McCann J, O'Driscoll D, Hunnam G, Warren RML.
Clinical Radiology. 56(1):44-49, 2001 Jan.
Breast
cancer survival by teaching status of the initial treating
hospital.
Chaudhry R, Goel V, Sawka C. CMAJ: Canadian Medical Association
Journal. 164(2):183-188, 2001 Jan 23.
Validity
of self-reported cancer history: A comparison of health interview
data and cancer registry records.
Desai
MM, Bruce ML, Desai RA, Druss BG. American
Journal of Epidemiology. 153(3):299-306, 2001 Feb 1.
Reproducibility
of reported farming activities and pesticide use among breast
cancer cases and controls: A comparison of two modes of data
collection.
Duell
EJ, Millikan RC, Savitz DA, et al. Annals
of Epidemiology. 11(3):178-185,
2001 Apr.
Incidence
of multiple primary cancers in a cohort of women diagnosed
with breast cancer in southeast England.
Evans HS, Lewis CM, Robinson D, Bell CMJ, Moller H, Hodgson
SV. British Journal of Cancer. 84(3):435-440, 2001 Feb 2.
Breast
cancer size and stage in Hispanic American women, by birthplace:
1992-1995.
Hedeen AN, White E. American Journal of Public Health. 91(1):122-125,
2001 Jan.
Racial
trends in age-specific breast cancer mortality rates in US
women.
Marbella AM, Layde PM. American Journal of Public Health.
91(1):118-121, 2001 Jan.
Race,
anthropometric factors, and stage at diagnosis of breast cancer.
Moorman PG, Jones BA, Millikan RC, Hall IJ, Newman B. American
Journal of Epidemiology. 153(3):284-291, 2001 Feb 1.
Age-period-cohort
modelling of breast cancer incidence in the Nordic countries.
Rostgaard K, Vaeth M, Holst H, Madsen M, Lynge E. Statistics
in Medicine. 20(1):47-61, 2001 Jan 15.
Breast
carcinoma presents a decade earlier in Mexican women than
in women in the United States or European countries.
Rodriguez-Cuevas
S, Macias CG, Franceschi D, Labastida S. Cancer. 91(4):863-868,
2001 Feb 15.
The
Cooperative Familial Registry for Breast Cancer Studies: design
and first year recruitment rates in Ontario.
Sutherland HJ, Lacroix J, Knight J, Andrulis LL, Boyd NF.
Journal of Clinical Epidemiology. 54(1):93-98, 2001 Jan.
Brachytherapy
in the elderly [Review].
Montemaggi P, Guerrieri P. Critical Reviews in Oncology-Hematology.
37(2):159-167, 2001 Feb.
Life
expectancy, comorbidity and quality of life: the treatment
equation in the older cancer patients [Review].
Repetto L, Comandini D, Mammoliti S. Critical Reviews in Oncology-Hematology.
37(2):147-152, 2001 Feb.
Perspectives
on comorbidity and cancer in older patients: Approaches to
expand the knowledge base.
Yancik R, Ganz PA, Varicchio CG, Conley B. Journal of Clinical
Oncology. 19(4):1147-1151, 2001 Feb 15.
Effect
of age and comorbidity in postmenopausal breast cancer patients
aged 55 years and older.
Yancik R, Wesley MN, Ries LAG, Havlik RJ, Edwards BK, Yates
JW. Jama: Journal of the American Medical Association. 285(7):885-892,
2001 Feb 21.
Original
report - Sonographic features of primary breast cancer in
men.
Yang WT, Whitman GJ, Yuen EHY, Tse GMK, Stelling CB. American
Journal of Roentgenology. 176(2):413-416, 2001 Feb.
Are
older lymphoma and breast cancer patients undertreated?
Oncology (Huntingt). 2001;15:406, 436.
Impact of mammographic interval on stage and survival after
the diagnosis of contralateral breast cancer.
Kaas
R, Hart AAM, Besnard APE, Peterse JL, Rutgers EJT. British
Journal of Surgery. 88(1):123-127, 2001 Jan.
Breast
cancer during the HIV epidemic in an African population.
Amir H, Makwaya C, Mhalu F, Mbonde MP, Schwartz-Albiez R.
Oncol Rep. 2001;8:659-61.
Health
Information on the Internet: Accessibility, Quality, and Readability
in English and Spanish.
Berland
GK, Elliott MN, Morales LS, et al. JAMA. 2001;285:2612-2621.
Cancer
care in Nepal: variables that affect diagnosis, treatment,
and prognosis: a case study.
Braun
CM, Itano JK. Cancer
Nurs. 2001;24:137-42.
The
impact of a multidisciplinary breast cancer center on recommendations
for patient management: the University of Pennsylvania experience.
Chang
JH, Vines E, Bertsch H, et al. Cancer.
2001;91:1231-7.
Similarities
of prostate and breast cancer: Evolution, diet, and estrogens.
Coffey DS. Urology. 2001;57:31-8.
Breast
cancer occurred after treatment for Hodgkin's disease: analysis
of 133 cases.
Cutuli B, Borel C, Dhermain F, et al. Radiother Oncol. 2001;59:247-55.
Computer
program to assist in making decisions about adjuvant therapy
for women with early breast cancer.
Ravdin
PM, Siminoff LA, Davis GJ, et al. Journal
of Clinical Oncology. 19(4):980-991, 2001 Feb 15.
Cognitive
function and reproductive hormones in adjuvant therapy for
breast cancer. a critical review.
Bender CM, Paraska KK, Sereika SM, Ryan CM, Berga SL. J Pain
Symptom Manage. 2001;21:407-24.
Sources
of elevated serum androgens in postmenopausal women who develop
breast cancer.
Dorgan
JF, Boudou P, Stanczyk FZ, et al. Cancer
Epidemiol Biomarkers Prev. 2001;10:407-10.
Variation
in mammographic breast density by race.
El-Bastawissi
AY, White E, Mandelson MT, Taplin S. Ann
Epidemiol. 2001;11:257-63.
Role
of Iron in Estrogen-Induced Cancer.
G Lieh J, Shawn
Jones J. Curr Med Chem. 2001;8:839-849.
In
situ and small invasive breast cancer register in Victoria,
1988 to 1992: Tumour characteristics and patient management.
Giles G, Russell I, Reed R, Marr G, Kavanagh A. Aust N Z J
Surg. 2001;71:266-270..
Change
in women's diet and body mass following intensive intervention
for early-stage breast cancer.
Hebert JR, Ebbeling CB, Olendzki BC, et al. J Am Diet Assoc.
2001;101:421-31.
Bericht
uber die NIH Consensus Development Conference zur adjuvanten
Therapie von Mammakarzinomen.
Kaufmann
M, von Minckwitz G. Onkologie. 2001;24:190-192.
Breast
cancer and NSAID use: a meta-analysis.
Khuder
SA, Mutgi AB. Br
J Cancer. 2001;84:1188-92.
Aichi
Cancer Center 10-year experience with conservative breast
treatment of early breast cancer: retrospective analysis regarding
failure patterns and factors influencing local control.
Kodaira
T, Fuwa N, Itoh Y, et al. Int
J Radiat Oncol Biol Phys. 2001;49:1311-6.
Glucose
metabolism of breast cancer assessed by F-18-FDG PET: Histologic
and immunohistochemical tissue analysis.
Avril
N, Menzel M, Dose J, et al. Journal
of Nuclear Medicine. 42(1):9-16, 2001 Jan.
Plasma
levels of vascular endothelial growth factor (VEGF) and its
receptor, Flt-1, in haematological cancers: A comparison with
breast cancer.
Belgore FM, Lip GYH, Bareford D, Wadley M, Stonelake P, Blann
AD. American Journal of Hematology. 66(1):59-61, 2001 Jan.
Expression
of CD44 isoforms in infiltrating lobular carcinoma of the
breast.
Berner HS, Nesland JM. Breast Cancer Research & Treatment.
65(1):23-29, 2001 Jan.
Monoclonality
in normal epithelium and in hyperplastic and neoplastic lesions
of the breast.
Diallo R, Schaefer KL, Poremba C, et al.
Journal of Pathology. 193(1):27-32, 2001 Jan.
Differences
in genetic alterations between primary lobular and ductal
breast cancers detected by comparative genomic hybridization.
Gunther K, Merkelbach-Bruse S, Amo-Takyi BK, Handt S, Schroder
W, Tietze L. Journal of Pathology. 193(1):40-47, 2001 Jan.
A
practical approach for evaluating new antibodies in the clinical
immunohistochemistry laboratory.
Hsi ED. Archives of Pathology & Laboratory Medicine. 125(2):289-294,
2001 Feb.
Immunohistochemical
study of the expression of MUC5AC and MUC6 in breast carcinomas
and adjacent breast tissues.
Pereira MB, Dias AJ, Reis CA, Schmitt FC. Journal of Clinical
Pathology. 54(3):210-213,
2001 Mar.
Image
cytometry in nonproliferative fibrocystic breast changes.
Azua-Romeo
J, de Azua-Blanco J, Romeo P. Ploidy evaluation and epidemiologic
study. Anal Quant Cytol Histol. 2001;23:129-34.
Molecular
targets for breast cancer therapy and prevention.
Bange J, Zwick E, Ullrich A. Nat Med. 2001;7:548-52.
General
articles of special interest to medical oncologists
The
effect of clodronate and antioestrogens on bone loss associated
with oestrogen withdrawal in postmenopausal women with breast
cancer.
Saarto
T, Vehmanen L, Elomaa I, Valimaki M, Makela P, Blomqvist C.
Br J Cancer. 2001;84:1047-51.
Breast
cancer after mantle irradiation for Hodgkin's disease: Correlation
of clinical, pathologic, and molecular features including
loss of heterozygosity at BRCA1 and BRCA2.
Gaffney DK, Hemmersmeier J, Holden J, et al. International
Journal of Radiation Oncology, Biology, Physics. 49(2):539-546,
2001 Feb 1.
Treatment of the jaundiced patient with breast carcinoma -
Case report and alternate therapeutic strategies.
Gurevich
I, Akerley W. Cancer. 91(4):660-663, 2001 Feb 15.
Pulmonary
sequelae of treatment for breast cancer: a prospective study.
Ooi
GC, Kwong DL, Ho JC, et al. Int
J Radiat Oncol Biol Phys. 2001;50:411-9.
Impact
of breast carcinoma on African-American women: the Detroit
experience.
Newman
LA, Carolin K, Simon M, et alCancer. 2001;91:1834-43.
A
case-control study of unilateral and bilateral breast carcinoma
patients.
Newman
LA, Sahin AA, Bondy ML, et al. Cancer.
2001;91:1845-53.
Risk
of colorectal cancer after breast cancer.
Newschaffer CJ, Topham A, Herzberg T, Weiner S, Weinberg DS.
Lancet. 2001;357:837-40.
Cancer
risk in a cohort of polio patients.
Nielsen NM, Wohlfahrt J, Aaby P, et al. Int J Cancer. 2001;92:605-8.
Preclinical
studies with zoledronic acid and other bisphosphonates: Impact
on the bone microenvironment.
Mundy GR, Yoneda T, Hiraga T. Semin
Oncol. 2001;28:35-44.
Acute
myeloid leukemia in patients previously diagnosed with breast
cancer: Experience of the GIMEMA group.
Pagano
L, Pulsoni A, Mele L, et al. Annals
of Oncology. 12(2):203-207, 2001 Feb.
Upper
gastrointestinal bleeding as a metastatic manifestation of
breast cancer: A case report and review of the literature.
Reiman T, Butts CA. Canadian Journal of Gastroenterology.
15(1):67-71, 2001 Jan.
Breast
cancer during pregnancy.
Gwyn
K, Theriault R. Oncology (Huntington). 15(1):39-+, 2001 Jan.
Patterns
of use of chemotherapy for breast cancer in older women: Findings
from Medicare claims data.
Du
XL, Goodwin JS. Journal
of Clinical Oncology. 19(5):1455-1461,
2001 Mar 1.
Impact
of systemic treatment on local control for patients with lymph
node-negative breast cancer treated with breast-conservation
therapy.
Buchholz
TA, Tucker SL, Erwin J, et al. J Clin Oncol. 2001;19:2240-6.
Centrally
necrotizing carcinomas of the breast - A distinct histologic
subtype with aggressive clinical behavior.
Jimenez
RE, Wallis T, Visscher DW. American
Journal of Surgical Pathology. 25(3):331-337,
2001 Mar.
An
association between cartilaginous tumours and breast cancer
in the national pathology registration in The Netherlands
points towards a possible genetic trait.
Odink AE, van Asperen CJ, Vandenbroucke JP, Cleton-Jansen
AM, Hogendoom PCW. Journal of Pathology. 193(2):190-192, 2001
Feb.
Magnetic
resonance pharmacoangiography to detect and predict chemotherapy
delivery to solid tumors.
Artemov D, Solaiyappan M, Bhujwalla ZM. Cancer Res. 2001;61:3039-44.
Paget
disease of the breast--an easily overlooked disease?
Sheen-Chen SM, Chen HS, Chen WJ, Eng HL, Sheen CW, Chou FF.
J Surg Oncol. 2001;76:261-5.
Management
of the pregnant mother with malignant conditions.
Sivanesaratnam V. Curr Opin Obstet Gynecol. 2001;13:121-5.
Positron
emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose
in oncology. Part IIIa: Therapy response monitoring in breast
cancer, lymphoma and gliomas.
van der Hiel B, Pauwels EK, Stokkel MP. J Cancer Res Clin
Oncol. 2001;127:269-77.
A
study of GP referrals to a family cancer clinic for breast/ovarian
cancer.
Watson E, Austoker J, Lucassen A. Fam Pract.
2001;18:131-4.
Monitoring
signal transduction in cancer: tyrosine kinase gene expression
profiling.
Weier HU, Zitzelsberger HF, Hsieh HB, et al. J Histochem Cytochem.
2001;49:673-4.
When
is a tumor marker ready for prime time? A case study of c-erbB-2
as a predictive factor in breast cancer.
Yamauchi H, Stearns V, Hayes DF. J Clin Oncol. 2001;19:2334-56.
Identification
of epitope regions recognized by tumor inhibitory and stimulatory
anti-erbb-2 monoclonal antibodies: implications for vaccine
design.
Yip YL, Smith G, Koch J, Dubel S, Ward RL. J Immunol.
2001;166:5271-8.
Novel
tumor-promoting property of tamoxifen.
Zhong
M, Lu Z, Abbas T, et al. Cell
Growth Differ. 2001;12:187-92.
Serological
markers for detection of cancer (Review).
Zusman I, Ben-Hur H. Int J Mol Med. 2001;7:547-56.
General
articles of special interest to surgical oncologists
Breast-conserving
therapy for early-stage breast cancer.
Mendenhall NP. Hematol Oncol Clin North Am. 2001;15:219-42.
Breast
cancer after augmentation mammoplasty.
Skinner KA, Silberman H, Dougherty W, et al. Annals of Surgical
Oncology. 8(2):138-144,
2001 Mar.
Physician
sex and other factors associated with type of breast cancer
surgery in older women.
Cyran EM, Crane LA, Palmer L. Archives of Surgery. 136(2):185-191,
2001 Feb.
Arm
edema in breast cancer patients [Review].
Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. J Natl
Cancer Inst. 93(2):96-111, 2001 Jan 17.
Clinical
practice guidelines for the care and treatment of breast cancer:
11.
Harris SR, Hugi MR, Olivotto IA, Levine M. Lymphedema. CMAJ:
Canadian Medical Association Journal. 164(2):191-199, 2001
Jan 23.
Surgical
outcomes after breast cancer surgery: Measuring acute lymphedema.
Kosir
MA, Rymal C, Koppolu P, et al. Journal
of Surgical Research. 95(2):147-151, 2001 Feb.
Lymphedema
[Review].
Rockson SG. American Journal of Medicine. 110(4):288-295,
2001 Mar.
Cancer
Risk at Sites Other than the Breast Following Augmentation
Mammoplasty.
Brinton LA, Lubin JH, Burich MC, Colton T, Brown SL, Hoover
RN. Ann Epidemiol. 2001;11:248-56.
Mortality
among augmentation mammoplasty patients
Brinton LA, Lubin JH, Burich MC, Colton T, Hoover RN.. Epidemiology.
2001;12:321-6.
Extra-abdominal
desmoid tumour of the breast: review of the primary management
and the implications for breast reconstruction.
Godwin Y, McCulloch TA, Sully L. Br J Plast Surg. 2001;54:268-71.
Breast
implants and cancer: causation, delayed detection, and survival.
Hoshaw SJ, Klein PJ, Clark BD, Cook RR, Perkins aL. Plast
Reconstr Surg. 2001;107:1393-407.
Volumes
of cancer surgery for breast, colorectal and ovarian cancer
1992-97: is there evidence of increasing sub-specialization
by surgeons?
Jolly K, Parry J, Rouse A, Stevens A. Br J Cancer. 2001;84:1308-13.
Quality
of life as an outcome measure in surgical oncology.
Langenhoff BS, Krabbe PF, Wobbes T, Ruers TJ. Br
J Surg. 2001;88:643-52.
MR
imaging-guided focused ultrasound surgery of fibroadenomas
in the breast: a feasibility study.
Hynynen K, Pomeroy O, Smith DN, et al. Radiology. 2001;219:176-85.
Factors
predicting the use of breast-conserving therapy in stage I
and II breast carcinoma.
Morrow M, White J, Moughan J, et al. J Clin Oncol. 2001;19:2254-62.
Immediate
breast reconstruction with saline-filled implants: no interference
with the oncologic outcome?
Vandeweyer E, Hertens D, Nogaret JM, Deraemaecker R. Plast
Reconstr Surg. 2001;107:1409-12.
A
comparison of aspiration cytology and core needle biopsy in
the evaluation of breast lesions.
Westenend PJ, Sever AR, Beekman-De Volder HJ, Liem SJ. Cancer.
2001;93:146-50.
Impact
of core-needle breast biopsy on the surgical management of
mammographic abnormalities.
White RR, Halperin TJ, Olson Jr JA, Soo MS, Bentley RC, Seigler
aH. Ann
Surg. 2001;233:769-77.
|
